RPG Life Sciences has a global map of satisfied customers and continues

to provide accessible quality healthcare to society

RPG Life Sciences is leading global trusted pharma brand

RPG Life Sciences, a part of RPG Enterprises, is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics and Synthetic APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines.

Recent News

ET Prime
RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-September..click for more details
30 Apr, 2026


RPG Life Sciences bets big on API business, eyes GLP-1 entry by August-September

RPG Life Sciences is prioritizing its API business for future growth, planning a significant acquisition to scale operations. The company also aims to enter the GLP-1 weight-loss therapy market by August-September. Despite geopolitical risks, RPG Life Sciences is strategically focusing on niche, complex molecules and expanding into new therapy areas.

 

- as per ET Prime

Click for more details

30 Apr, 2026

Capital Market MSN
RPG Life Sciences posts PAT of Rs 29.9 crore in Q4 FY26..click for more details
30 Apr, 2026


RPG Life Sciences posts PAT of Rs 29.9 crore in Q4 FY26

Ashok Nair, managing director, RPG Life Sciences, said:

"Overall, we have built solid momentum with healthy growth in Q4 and for the full fiscal year, driven by sharper field effectiveness, operational discipline and an unwavering focus on our key brands.

Looking ahead, we intend to strengthen our new product pipeline, sharpen equity of our existing brands, and drive field force effectiveness."

- as per Capital Market MSN

Click for more details

30 Apr, 2026

CNBC TV18
RPG Life Sciences sees API rebound driving growth, margins to stay steady..click for more details
30 Apr, 2026


RPG Life Sciences sees API rebound driving growth, margins to stay steady

Ashok Nair, MD of RPG Life Sciences said the company delivered strong revenue and profit growth, with expansion across therapy areas and stable margins expected going forward, supported by pricing actions and business expansion.

- as per CNBC TV18

Click for more details

30 Apr, 2026

Business Standard
Q4 earnings, dividend news trigger 14% jump in RPG Life Sciences shares..click for more details
30 Apr, 2026


Q4 earnings, dividend news trigger 14% jump in RPG Life Sciences shares

The board of RPG Life Sciences Technologies has recommended a dividend of ₹24 per equity share, or 300 per cent on the face value of ₹8 per share, fully paid up, for FY26

- as per Business Standard

Click for more details

30 Apr, 2026

Money Control
Bajaj Finance, RPG Life gain post Q4 earnings; Indian Hume up 5% on contract win Read More: https:..click for more details
30 Apr, 2026


Bajaj Finance, RPG Life gain post Q4 earnings; Indian Hume up 5% on contract win Read More: https:

Bajaj Finance share price rose 4 percent after reporting a strong operational performance, with its Q4 consolidated profit rising 22 percent year-on-year to Rs 5,553 crore.

- as per Money Control

Click for more details

30 Apr, 2026

CNBC TV18
RPG Life Sciences Q4 Results: Operating performance strong, base quarter one-off impacts profit..click for more details
30 Apr, 2026


RPG Life Sciences Q4 Results: Operating performance strong, base quarter one-off impacts profit

Shares of RPG Life Sciences Ltd ended at ₹2,024.05, down by ₹34.70, or 1.69%, on the BSE.

- as per CNBC TV18

Click for more details

30 Apr, 2026

Equity Master
RPG LIFE SCIENCES Gains 10%; BSE HEALTHCARE Index Down 0.5%..click for more details
30 Apr, 2026


RPG LIFE SCIENCES Gains 10%; BSE HEALTHCARE Index Down 0.5%

RPG LIFE SCIENCES share price has zoomed 10% and is presently trading at Rs 2,228.4.

- as per Equity Master

Click for more details

30 Apr, 2026

Zee Business
Ashok Nair MD, RPG Life Sciences speaks to ZEE Business on the company's Q4 FY26 performance..click for more details
30 Apr, 2026


Ashok Nair MD, RPG Life Sciences speaks to ZEE Business on the company's Q4 FY26 performance

Ashok Nair MD, RPG Life Sciences speaks to ZEE Business on the company's Q4 FY26 performance

- as per Zee Business

Click for more details

30 Apr, 2026



New Products

Employee Connect Initiatives

We believe in people as our best assets. So, we at RPGLS have several Employee Connect Initiatives such as Hello Happiness Forums, Happy Talk, etc.

Read More at Employee Connect

Managing DirectorRPG Life Sciences Limited

Operations

Business Portfolio

RPG Life Sciences operates through three business verticals – API, Domestic Formulations and International Formulations.

Therapeutic Focus

We have a diverse product portfolio spanning over 10 therapeutic areas including Nephrology, Oncology, Urology, Respiratory, etc.

Facilities

Our Formulations facilities are located at Ankleshwar, Gujarat and Synthetic API facility is located at Navi Mumbai.

Quality

Quality is considered paramount by us during development, manufacture and testing of our products.

Company Awards

Flexible rewards policy and work-life balance programs reflect our emphasis on employees.

Research and Development

Formulation Research & Development forms the most significant pillar of our growth strategy.

Corporate Social Responsibility

Our vision is to drive holistic empowerment of the community around the local vicinity of our plants and society at large.

Environment and Sustainability

Environment, Health and Safety has been one of our key areas where there has been a constant endeavor to excel.

Our History and Milestones

RPGLS @ Industry Platforms

Investor Relations

Investor Relations Section includes one click access to statutory information and data sought by the investors. Investors can have a look at Company Presentations, Financial Reports, Annual Reports, Corporate Governance reports, Composition of Committees, etc.

Annual Reports

And we have products that take care of patients make people happy

70,000+ doctors in 52 countries prescribe RPG Life Sciences products for over 10 therapies. Our leading brands are: